Oct 7, 2026 · 16 min
Chinese chemical suppliers move from fentanyl to peptides
Why Chinese Fentanyl Factories Are Making Peptides Now
The episode shows how weak oversight and strong U.S. demand are helping an unapproved peptide market expand across borders.
- 1Fentanyl precursor suppliers are finding a lucrative replacement market as Chinese controls and enforcement pressure increase.
- 2Consumers are buying experimental peptides online for weight loss, beauty, recovery, and wellness despite limited validation and regulatory approval.
- 3Mislabeled shipments, cryptocurrency payments, and fragmented enforcement make the growing gray market difficult to contain.
Don't miss
Henri Rinchen’s online storefront and alleged willingness to ship fentanyl precursors show how easily a supplier can present itself as an accessible chemical retailer.
The brief
Chinese chemical manufacturers once associated with fentanyl precursor production are pivoting toward peptides, turning a crackdown on one market into an opening for another.
Henri Rinchen’s online storefront illustrates the model: direct contact with buyers, promises of customs clearance, and a catalog spanning obscure chemical products.
The U.S. Justice Department indicted Henri Rinchen after an undercover investigation, but a company based in China is not compelled to answer U.S. charges.
America’s peptide boom is driven by influencers and demand for weight loss, beauty, tanning, recovery, and wellness products—many of them unapproved or inadequately validated.
Sellers use mislabeled packages and cryptocurrency while consumers prioritize convenience and low prices, allowing a fast-moving gray market to outpace oversight.